|
| 37673749 | Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET. | Am J Geriatr Psychiatry | 2024 |
| 37955791 | The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [<sup>11</sup>C]UCB-J. | Eur J Nucl Med Mol Imaging | 2024 |
| 36449413 | Lecanemab in Early Alzheimer's Disease. | N Engl J Med | 2023 |
| 37693474 | Sex differences in the pleiotropy of hearing difficulty with imaging-derived phenotypes: a brain-wide investigation. | medRxiv | 2023 |
| 38042785 | Aging gene signature of memory CD8<sup>+</sup> T cells is associated with neurocognitive functioning in Alzheimer's disease. | Immun Ageing | 2023 |
| 37538343 | Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study. | Alzheimers Dement (N Y) | 2023 |
| 37874022 | Localization of PDE4D, HCN1 channels, and mGluR3 in rhesus macaque entorhinal cortex may confer vulnerability in Alzheimer's disease. | Cereb Cortex | 2023 |
| 37458272 | Trial of Solanezumab in Preclinical Alzheimer's Disease. | N Engl J Med | 2023 |
| 37422964 | Principal component analysis of synaptic density measured with [<sup>11</sup>C]UCB-J PET in early Alzheimer's disease. | Neuroimage Clin | 2023 |
| 37187779 | Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials. | Alzheimers Dement (N Y) | 2023 |
| 36946443 | Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab. | J Prev Alzheimers Dis | 2023 |
| 37382240 | Relationships of in vivo brain norepinephrine transporter and age, BMI, and gender. | Synapse | 2023 |
| 37099355 | Lecanemab in Early Alzheimer's Disease. Reply. | N Engl J Med | 2023 |
| 37099351 | Lecanemab in Early Alzheimer's Disease. | N Engl J Med | 2023 |
| 37066690 | Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2). | Int Psychogeriatr | 2023 |
| 37066364 | Aging gene signature of IL-7 receptor alpha low effector memory CD8<sup>+</sup> T cells is associated with neurocognitive functioning in Alzheimer's disease. | Res Sq | 2023 |
| 36599073 | Response to: Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke. | N Engl J Med | 2023 |
| 36526112 | Aging of the brain in bipolar disorder: Illness- and onset-related effects in cortical thickness and subcortical gray matter volume. | J Affect Disord | 2023 |
| 36627206 | Natural cubic splines for the analysis of Alzheimer's clinical trials. | Pharm Stat | 2023 |
| 34924392 | Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort. | J Alzheimers Dis | 2022 |
| 35581440 | Alzheimer disease neuropathology in a patient previously treated with aducanumab. | Acta Neuropathol | 2022 |
| 35542991 | Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease. | J Prev Alzheimers Dis | 2022 |
| 35357236 | Emotion Processing Dysfunction in Alzheimer's Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology. | Am J Alzheimers Dis Other Demen | 2022 |
| 36314209 | Hypothalamic Functional Connectivity and Apathy in People with Alzheimer's Disease and Cognitively Normal Healthy Controls. | J Alzheimers Dis | 2022 |
| 35907208 | Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer's disease. | Aging (Albany NY) | 2022 |
| 36371232 | Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease. | Alzheimers Res Ther | 2022 |
| 36121669 | Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials. | JAMA Neurol | 2022 |
| 35174954 | Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [<sup>11</sup> C]UCB-J. | Alzheimers Dement | 2022 |
| 34963063 | Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease. | Neurobiol Aging | 2022 |
| 32461027 | Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. | Am J Geriatr Psychiatry | 2021 |
| 33829643 | Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates. | Alzheimers Dement | 2021 |
| 33766236 | Amyloid-Associated Depression-or Not? | Biol Psychiatry | 2021 |
| 33757318 | Comparison of [<sup>11</sup>C]UCB-J and [<sup>18</sup>F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study. | J Cereb Blood Flow Metab | 2021 |
| 33831179 | Pleiotropic effects of telomere length loci with brain morphology and brain tissue expression. | Hum Mol Genet | 2021 |
| 34430703 | Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. | Alzheimers Dement (Amst) | 2021 |
| 34570180 | Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. | JAMA Neurol | 2021 |
| 34482052 | Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis. | Psychiatry Res Neuroimaging | 2021 |
| 34224153 | Generation of synthetic PET images of synaptic density and amyloid from <sup>18</sup> F-FDG images using deep learning. | Med Phys | 2021 |
| 34155411 | A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. | Nat Med | 2021 |
| 34297895 | Recruitment of a multi-site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial. | Alzheimers Dement | 2021 |
| 34119639 | Partial volume correction analysis for <sup>11</sup>C-UCB-J PET studies of Alzheimer's disease. | Neuroimage | 2021 |
| 34052464 | Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [[18]F]FPEB PET. | Neuroimage | 2021 |
| 34000404 | Identifying brain networks in synaptic density PET (<sup>11</sup>C-UCB-J) with independent component analysis. | Neuroimage | 2021 |
| 33402201 | Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [<sup>11</sup>C]UCB-J. | Alzheimers Res Ther | 2021 |
| 33047474 | Alzheimer's & Dementia: The Journal of the Alzheimer's Association. | Alzheimers Dement | 2021 |
| 32646875 | Simplified Quantification of <sup>11</sup>C-UCB-J PET Evaluated in a Large Human Cohort. | J Nucl Med | 2021 |
| 32565008 | Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. | Am J Geriatr Psychiatry | 2021 |
| 32400950 | In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET. | Alzheimers Dement | 2020 |
| 31906973 | Classical complement cascade initiating C1q protein within neurons in the aged rhesus macaque dorsolateral prefrontal cortex. | J Neuroinflammation | 2020 |
| 32053667 | Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results. | PLoS One | 2020 |